Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily M Ko

Showing results (21-30 of 127) with videos related to

Pageof 13
Sort By:
Gynecologic Oncology Reports|February 23, 2024
Prior authorization for FDA-approved PARP inhibitors in ovarian cancerAnna Jo Bodurtha Smith, Annie Apple, Audra Hugo, et al.
American Journal of Obstetrics and Gynecology|September 30, 2024
Disparities in clinical drug trial participation in endometrial cancer: a real-world analysisAnna Jo Bodurtha Smith, Sebastian Spataro, Jonathan Heintz, et al.
Gynecologic Oncology|January 13, 2021
Impact of past surgical history on perioperative outcomes in gynecologic surgeryEmily M Ko, Diego Aviles, Nathanael C Koelper, et al.
Gynecologic Oncology|June 10, 2023
Disparities in clinical trial participation in ovarian cancer: A real-world analysisAnna Jo Bodurtha Smith, Rafael Alvarez, Jonathan Heintz, et al.
Archives of Gynecology and Obstetrics|June 11, 2020
Ovarian Sertoli-Leydig and granulosa cell tumor: comparison of epidemiology and survival outcomesDimitrios Nasioudis, Spyridon A Mastroyannis, Ashley F Haggerty, et al.
Gynecologic Oncology Reports|September 2, 2022
Predictive value of 5-Factor modified frailty index in Oncologic and benign hysterectomiesCatherine E Hermann, Nathanael C Koelper, Leslie Andriani, et al.
American Journal of Obstetrics and Gynecology|December 13, 2016
Survival implications of time to surgical treatment of endometrial cancersDavid I Shalowitz, Andrew J Epstein, Lindsey Buckingham, et al.
Gynecologic Oncology|February 6, 2024
Variation in telemedicine usage in gynecologic cancer: Are we widening or narrowing disparities?Anna Jo Bodurtha Smith, Emily G Gleason, Leslie Andriani, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 15, 2019
Ovarian preservation for low-grade endometrial stromal sarcoma: a systematic review of the literature and meta-analysisDimitrios Nasioudis, Emily M Ko, Georgios Kolovos, et al.
Gynecologic Oncology|May 1, 2024
"Having cancer is very expensive": A qualitative study of patients with ovarian cancer and PARP inhibitor treatmentAnna Jo Bodurtha Smith, Caroline O'Brien, Ashley Haggerty, et al.
Pageof 13

Showing results (21-30 of 127) with videos related to

Sort By:
Pageof 13
Gynecologic Oncology Reports|February 23, 2024
Prior authorization for FDA-approved PARP inhibitors in ovarian cancerAnna Jo Bodurtha Smith, Annie Apple, Audra Hugo, et al.
American Journal of Obstetrics and Gynecology|September 30, 2024
Disparities in clinical drug trial participation in endometrial cancer: a real-world analysisAnna Jo Bodurtha Smith, Sebastian Spataro, Jonathan Heintz, et al.
Gynecologic Oncology|January 13, 2021
Impact of past surgical history on perioperative outcomes in gynecologic surgeryEmily M Ko, Diego Aviles, Nathanael C Koelper, et al.
Gynecologic Oncology|June 10, 2023
Disparities in clinical trial participation in ovarian cancer: A real-world analysisAnna Jo Bodurtha Smith, Rafael Alvarez, Jonathan Heintz, et al.
Archives of Gynecology and Obstetrics|June 11, 2020
Ovarian Sertoli-Leydig and granulosa cell tumor: comparison of epidemiology and survival outcomesDimitrios Nasioudis, Spyridon A Mastroyannis, Ashley F Haggerty, et al.
Gynecologic Oncology Reports|September 2, 2022
Predictive value of 5-Factor modified frailty index in Oncologic and benign hysterectomiesCatherine E Hermann, Nathanael C Koelper, Leslie Andriani, et al.
American Journal of Obstetrics and Gynecology|December 13, 2016
Survival implications of time to surgical treatment of endometrial cancersDavid I Shalowitz, Andrew J Epstein, Lindsey Buckingham, et al.
Gynecologic Oncology|February 6, 2024
Variation in telemedicine usage in gynecologic cancer: Are we widening or narrowing disparities?Anna Jo Bodurtha Smith, Emily G Gleason, Leslie Andriani, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 15, 2019
Ovarian preservation for low-grade endometrial stromal sarcoma: a systematic review of the literature and meta-analysisDimitrios Nasioudis, Emily M Ko, Georgios Kolovos, et al.
Gynecologic Oncology|May 1, 2024
"Having cancer is very expensive": A qualitative study of patients with ovarian cancer and PARP inhibitor treatmentAnna Jo Bodurtha Smith, Caroline O'Brien, Ashley Haggerty, et al.
Pageof 13